- ¹â¸F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma
-
Laudicella R, Davidzon G, Vasanawala S, Baldari S, Iagaru A
- KMID: 2455525
- Nucl Med Mol Imaging.
- 2019 Aug;53(4):296-299.
- doi: 10.1007/s13139-019-00597-8
We described the clinical impact of ¹â¸F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma.We detailed the diagnostic imaging workup focusing our attention... -
- CITED
-
- Close
- SHARE
-
- Close
- Peptide Receptor Radionuclide Therapy of Pulmonary Neuroendocrine Neoplasms: a Single-Centre Experience
-
Minutoli F, Cardile D, Laudicella R, Vento A, Pagano B, Baldari S
- KMID: 2512967
- Nucl Med Mol Imaging.
- 2021 Feb;55(1):38-45.
- doi: 10.1007/s13139-020-00679-y
Purpose Peptide receptor radionuclide therapy represents a therapeutic option for neuroendocrine neoplasms; to date, experiences with peptide receptor radionuclide therapy of pulmonary neuroendocrine neoplasms are still limited. We report our... -
- CITED
-
- Close
- SHARE
-
- Close
